After the launches in the UK, Germany and Norway in Q4 2019 and in Belgium and the Netherlands in Q1 2020, Efemia will be available in markets with more than 8 million potential users. We will then plan a launch in the United States at the same time as we develop/evaluate additional products.
Forecast: Potential Efemia users
- 2018 – 0.5 million (swe)
- 2019 – 8 million (+dan, ger, uk, nor)
- 2020 – 15 million (+ned, bel and more eu countries)
- 2021 – 35 million (+the us and additional countries)
The forecast is based on Invent Medic’s expansion plans and an estimation of women with bothersome SUI in each market. In studies, around 70% of the participants have stated that they see themselves continue to use Efemia.